According to a new report by Univdatos Market Insights, the MENA Generic Oncology Drug Market is expected to reach USD 7.5 Billion in 2032 by growing at a CAGR of 3%. The Middle East and North Africa (MENA) region is witnessing a notable surge in the demand for oncology drugs, driven by the increasing prevalence of cancer and the need for affordable treatment options. Within this landscape,...